TGM2 and cranioectodermal dysplasia: Monitoring the appearance of anti-TG2 antibodies in the serum, elevated IgA antibodies to TG2 were detected in all evaluable 24 CeD cases by the chip method, but only in the samples collected at the time of CeD diagnosis (Figure 6A).